EHTH Stock Analysis: Buy, Sell, or Hold?
EHTH - eHealth, Inc.
$1.26
0.03 (2.44%)
â˛
5d:
+5.0%
30d:
-5.97%
90d:
-20.25%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 04, 2026
0d
Get Alerted When EHTH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: EHTH is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: EHTH is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: EHTH is currently trading at $1.26, which is considered slightly low relative to its 30-day fair value range of $1.23 to $1.41. From a valuation perspective, the stock is trading at a discount (Forward PE: -1.3) compared to its historical average (1.8). At these levels, the market is pricing in 0% annual earnings growth.
Technical Outlook: Technically, EHTH is in a downtrend. Immediate support is located at $1.19, while resistance sits at $1.39.
Market Sentiment: The stock scores a mixed 56/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $2.06 (+67.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, EHTH is in a downtrend. Immediate support is located at $1.19, while resistance sits at $1.39.
Market Sentiment: The stock scores a mixed 56/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $2.06 (+67.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.23 -
$1.41
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (56/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 67.7% below Wall St target ($2.06)
- WARNING: Composite score 48/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.23 -
$1.41
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.19
Resistance Level
$1.39
Current Trend
Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.26
Wall Street Target
$2.06
(+67.7%)
Revenue Growth (YoY)
-44.8%
Earnings Growth (YoY)
-17.6%
Profit Margin
5.4%
PE vs Historical
-1.3 vs 1.8
CHEAP
Share & Embed Analysis
Last updated: August 24, 2026 10:08 AM ET
Data refreshes hourly during market hours. Next update: 11:08 AM
Data refreshes hourly during market hours. Next update: 11:08 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EHTH showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
John Joseph Dolan
BUY
25000 shares
2026-03-06
Top Rated Insurance Brokers Stocks
Top-rated stocks in Insurance Brokers by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AJG
Arthur J Gallagher & Co |
BUY
22 analysts |
$292 | 41 HOLD |
|
AON
Aon PLC |
HOLD
20 analysts |
$404 | 64 BUY |
|
WTW
Willis Towers Watson PLC |
STRONG BUY
18 analysts |
$380 | 45 HOLD |
|
MMC
Marsh & McLennan CompaniâĻ |
SELL
20 analysts |
$211 | 49 HOLD |
|
GOCO
GoHealth Inc. |
STRONG BUY
5 analysts |
$5 | 52 HOLD |
